SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Repligen Corp (RGEN)
RGEN 160.67-0.1%Dec 9 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Curtis E. Bemis who wrote (148)9/7/1999 11:13:00 AM
From: LLCF  Read Replies (1) of 395
 
<"These grant awards are consistent with our strategy of obtaining third party funding for preclinical research projects in order to focus our proprietary investments on the clinical development of secretin for autism and CTLA4 for organ transplantation,">

Haven't followed these guys till they obtained secretin, but now it's their main focus??? Has this company been around the block or what? They're going to need some coin and savy to take secretin all the way through it seems to me. Do they have any cash?

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext